Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo
Number of days in hospital · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in number of days in hospital compared with placebo; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesBMT/SCT after conditioning for haematological cancersMD 0.00 [-1.64, 1.64]1 study · 281 participantsGRADE not reported